{"id":"W4290973142","doi":"10.1016/s0140-6736(22)01337-x","title":"Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study","year":2022,"lang":"en","type":"article","venue":"The Lancet","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"Agios Pharmaceuticals","keywords":"Medicine; Internal medicine; Clinical endpoint; Blood transfusion; Pediatrics; Pyruvate kinase; Anemia; Thalassemia; Adverse effect; Gastroenterology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008291656,0.0002740011,0.0007893068,0.0001003987,0.0002959703,0.00003416534,0.0005080602,0.00009112066,0.0002203036],"category_scores_gemma":[0.00006103564,0.0001620492,0.00002075754,0.0005006653,0.0001167449,0.0002266787,0.0002850823,0.0007973971,0.000002493429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001142327,"about_ca_system_score_gemma":0.0001651764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001315979,"about_ca_topic_score_gemma":0.001383555,"domain_scores_codex":[0.9977231,0.0003966596,0.0004373169,0.0005235887,0.0004774449,0.0004418685],"domain_scores_gemma":[0.9986616,0.0001136456,0.0001610017,0.0008019331,0.00006039623,0.0002014468],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5205591,0.06970575,0.2349487,0.0005934161,0.0007138813,0.003049311,0.05219981,0.001006216,0.04502488,0.00006403598,0.0007171183,0.07141777],"study_design_scores_gemma":[0.6110111,0.05955791,0.2371021,0.0009551649,0.0008651618,0.0002863024,0.07587994,0.007393254,0.003933304,0.00002964672,0.00197869,0.001007447],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954838,0.0001444193,0.00000859861,0.0008093772,0.00008728989,0.002868253,0.0000824568,0.00004559497,0.000470259],"genre_scores_gemma":[0.9987521,0.0003571286,0.0002005785,0.0003014299,0.00005826346,0.00007610142,0.00008271907,0.00004764899,0.0001239867],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09045204,"threshold_uncertainty_score":0.6608175,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02653289840371956,"score_gpt":0.318073406315061,"score_spread":0.2915405079113414,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}